Robak T - Search Results

1

Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized clinical trials.

Puła A, Stawiski K, Braun M, Iskierka-Jażdżewska E, Robak T. Puła A, et al. Among authors: robak t. Leuk Lymphoma. 2018 May;59(5):1084-1094. doi: 10.1080/10428194.2017.1375101. Epub 2017 Sep 11. Leuk Lymphoma. 2018. PMID: 28891366

2

Expression of the multidrug resistance-associated protein (mrp) gene in chronic lymphocytic leukemia.

Juszczyński P, Niewiarowski W, Krykowski E, Robak T, Warzocha K. Juszczyński P, et al. Among authors: robak t. Leuk Lymphoma. 2002 Jan;43(1):153-8. doi: 10.1080/10428190210198. Leuk Lymphoma. 2002. PMID: 11908721

3

The search for optimal treatment in relapsed and refractory acute myeloid leukemia.

Robak T, Wrzesień-Kuś A. Robak T, et al. Leuk Lymphoma. 2002 Feb;43(2):281-91. doi: 10.1080/10428190290006053. Leuk Lymphoma. 2002. PMID: 11999559 Review.

4

The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials.

Robak T. Robak T. Leuk Lymphoma. 2002 Mar;43(3):537-48. doi: 10.1080/10428190290012029. Leuk Lymphoma. 2002. PMID: 12002757 Review.

5

The influence of low molecular weight heparin on the intravascular activation of the coagulation system in patients with acute leukemia during induction chemotherapy--report of a prospective randomized study.

Chojnowski K, Treliński J, Wawrzyniak E, Robak T. Chojnowski K, et al. Among authors: robak t. Leuk Lymphoma. 2002 May;43(5):1021-8. doi: 10.1080/10428190290022164. Leuk Lymphoma. 2002. PMID: 12148881 Clinical Trial.

6

Aggressive primary plasma cell leukemia with skin manifestations, trisomy 8 and molecular oligoclonal features.

Robak T, Urbańska-Rys H, Robak E, Bartkowiak J, Strzelecka B, Biernat W, Kordek R. Robak T, et al. Among authors: robak e. Leuk Lymphoma. 2002 May;43(5):1067-73. doi: 10.1080/10428190290021696. Leuk Lymphoma. 2002. PMID: 12148888

7

Acute lymphoblastic leukemia in adult first manifested as severe aplastic anemia--role of molecular analysis in correct diagnosis.

Robak T, Bartkowiak J, Urbańska-Rys H, Szmigielska-Kapłon A, Strzelecka B, Chojnowski K. Robak T, et al. Leuk Lymphoma. 2002 May;43(5):1147-52. doi: 10.1080/10428190290021605. Leuk Lymphoma. 2002. PMID: 12148900

8

Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment.

Robak T, Boński JZ, Kasznicki M, Góra-Tybor J, Hellmann A, Konopka L, Dmoszyńska A, Dwilewicz-Trojaczek J, Wołowiec D; Polish Leukemia Study Group. Robak T, et al. Eur J Haematol. 2002 Jul;69(1):27-36. doi: 10.1034/j.1600-0609.2002.02711.x. Eur J Haematol. 2002. PMID: 12270059

9

Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia.

Robak T, Błoński JZ, Kasznicki M, Góra-Tybor J, Dwilewicz-Trojaczek J, Stella-Hołowiecka B, Wołowiec D. Robak T, et al. Hematol J. 2002;3(5):244-50. doi: 10.1038/sj.thj.6200191. Hematol J. 2002. PMID: 12391542 Clinical Trial.

10

Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophosphamide.

Robak T, Kordek R, Robak E, Bartkowiak J, Biernat W, Liberski P, Błoński J. Robak T, et al. Among authors: robak e. Leuk Lymphoma. 2002 Oct;43(10):2041-6. doi: 10.1080/1042819021000015998-1. Leuk Lymphoma. 2002. PMID: 12481906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters